Factors that influence whether patients with cancer involve families in decision-making identified
the ONA take:
According to a new study published in the journal Cancer, researchers from Harvard Medical School in Boston, Massachusetts, have identified certain factors that influence whether patients with cancer involve their family members in treatment decisions.
For the study, researchers surveyed 5,284 patients with newly diagnosed colon or lung cancer, and asked them how they involved their family members in treatment decisions.
Results showed that only 1.5% of participants reported family-controlled decisions, while 49.4% reported equally sharing decisions with family members, 22.1% report some input from family members, and 28.5% reported little to no input from family members.
The researchers also found that non-English speaking Asian patients and Spanish-speaking Hispanic patients were more likely to equally share decisions with their family members compared with other patients.
Patients who were female, insured, married, and older were also more often to equally share decisions with their family members versus other patients, while veterans were least likely to involve family members in treatment decisions.
The authors hope that the findings will help physicians to better assess their patients' preferences for involving their families in treatment decisions.
Certain factors influence whether patients with cancer involve their family members in treatment decisions.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|